ELI LILLY & Co 8-K
Research Summary
AI-generated summary
Eli Lilly & Co Reports 2026 Annual Meeting Voting Results
What Happened
- Eli Lilly & Company held its 2026 Annual Meeting of Shareholders on May 4, 2026 and filed an 8‑K on May 7, 2026 reporting the vote results. A total of 847,254,010 shares were voted (≈90% of 944,818,881 outstanding shares as of the Feb. 25, 2026 record date).
- Four director nominees were elected to three‑year terms ending in 2029: Carolyn Bertozzi (For: 761,930,361), William Kaelin, Jr. (For: 726,270,361), Jon Moeller (For: 749,926,634), and David Ricks (For: 734,760,028). The advisory vote on executive compensation (say‑on‑pay) was approved (For: 731,998,717). Ernst & Young LLP was ratified as the independent auditor for 2026 (For: 802,721,381).
- Two proposed amendments to the Articles — to eliminate the classified board structure and to remove supermajority voting provisions — did not meet the required 80% approval threshold and therefore failed (classified board amendment For: 665,371,049; supermajority amendment For: 664,460,262). Shareholder proposals to require an independent board chair and to prepare an annual lobbying report were also not approved.
Key Details
- Shares voted: 847,254,010 (≈90% of 944,818,881 outstanding as of Feb. 25, 2026).
- Director vote highlights: Bertozzi 761,930,361 For; Kaelin 726,270,361 For; Moeller 749,926,634 For; Ricks 734,760,028 For. Broker nonvotes for director elections: 82,485,329.
- Governance amendment outcomes: Classified board amendment — For 665,371,049 / Against 97,677,173; Supermajority amendment — For 664,460,262 / Against 98,597,088 (both failed to reach required 80%).
- Other votes: Say‑on‑pay — For 731,998,717; Auditor ratification — For 802,721,381. Independent chair proposal — For 257,292,684; Annual lobbying report — For 113,417,917.
Why It Matters
- The results confirm continuity in board composition and investor support for executive compensation and the auditor, signaling stability in leadership and oversight.
- The failure of the governance amendments (high 80% threshold) means Lilly will retain its classified board structure and supermajority voting provisions for now, which can affect how quickly governance changes can be implemented in the future.
- Retail investors should note turnout and vote margins as indicators of shareholder engagement and where investor sentiment is strongest (e.g., opposition majorities on certain governance and policy proposals).
Loading document...